相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
Xiao-li Wei et al.
BMC CANCER (2015)
Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials
M. Peeters et al.
EUROPEAN JOURNAL OF CANCER (2015)
Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients
Harry H. Yoon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
Rafal Stec et al.
ONCOLOGY LETTERS (2015)
Prevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancer
Lee Cheng Phua et al.
ONCOLOGY LETTERS (2015)
Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases
Jing Zhang et al.
SCIENTIFIC REPORTS (2015)
Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients
Harry H. Yoon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
A Pathway-Centric Survey of Somatic Mutations in Chinese Patients with Colorectal Carcinomas
Chao Ling et al.
PLOS ONE (2015)
Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147
Wilson I. Gonsalves et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma
Swati Bisht et al.
MEDICAL ONCOLOGY (2014)
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study
Serban Negru et al.
BMJ OPEN (2014)
Indian Council of Medical Research consensus document for the management of colorectal cancer
Bhawna Sirohi et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2014)
KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
A. I. Phipps et al.
BRITISH JOURNAL OF CANCER (2013)
Characterization and Prognostic Value of Mutations in Exons 5 and 6 of the p53 Gene in Patients with Colorectal Cancers in Central Iran
Rahim Golmohammadi et al.
GUT AND LIVER (2013)
Kras Gene Mutation and RASSF1A, FHIT and MGMT Gene Promoter Hypermethylation: Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population
Rupal Sinha et al.
PLOS ONE (2013)
PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
Christophe Rosty et al.
PLOS ONE (2013)
Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany
Ondrej Majek et al.
PLOS ONE (2013)
Effectors of Epidermal Growth Factor Receptor Pathway: The Genetic Profiling of KRAS, BRAF, PIK3CA, NRAS Mutations in Colorectal Cancer Characteristics and Personalized Medicine
Yinchen Shen et al.
PLOS ONE (2013)
Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians
Pooja Malhotra et al.
TUMOR BIOLOGY (2013)
RAS signaling pathways, mutations and their role in colorectal cancer
Kypros Zenonos et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2013)
Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution
Brooke E. Sylvester et al.
CLINICAL CANCER RESEARCH (2012)
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
Grazia Palomba et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy
M. Colombino et al.
CELL DEATH & DISEASE (2012)
NRAS Mutations Are Rare in Colorectal Cancer
Natsumi Irahara et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
F. Loupakis et al.
BRITISH JOURNAL OF CANCER (2009)
The Difference in p53 Mutations between Cancers of the Upper and Lower Gastrointestinal Tract
Eiji Oki et al.
DIGESTION (2009)
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer
Jens Neumann et al.
PATHOLOGY RESEARCH AND PRACTICE (2009)
Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
Ludovic Barault et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients
Chang-Ho Jeon et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Population differences in familial adenomatous polyposis may be an expression of geographic differences in APC mutation pattern
Thomas M. Attard et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis - Proposal for new molecular profile of colorectal carcinomas
T Sugai et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Increasing incidence of colorectal cancer in Asia: implications for screening
JJY Sung et al.
LANCET ONCOLOGY (2005)
The TP53 Colorectal Cancer International Collaborative Study on the prognostic and predictive significance of p53 mutation:: Influence of tumor site, type of mutation, and adjuvant treatment
A Russo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma
A Conlin et al.
GUT (2005)
Mutation analysis of p53, k-ras, and BRAF genes in colorectal cancer progression
D Calistri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
p53 mutation heterogeneity in cancer
T Soussi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer
Zhi-Zhong Pan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study
M Lüchtenborg et al.
CARCINOGENESIS (2004)
Significance of TP53 mutations in human cancer:: a critical analysis of mutations at CpG dinucleotides
T Soussi et al.
HUMAN MUTATION (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer
G Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Prognostic significance of P53 mutations in colon cancer at the population level
WS Samowitz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The ABC of APC
NS Fearnhead et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
